PHA Pharmagest Interactive SA

Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS

Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS

        

Villers-lès-Nancy, 10 June 2024 - 6:00 p.m. (CET)

PRESS RELEASE

ANNUAL ORDINARY GENERAL MEETING

MEETING NOTICE

ON-LINE AVAILABILITY OF MEETING MATERIALS

EQUASENS hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 27, 2024 at 5.30 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud).

The original French language version of the agenda and the resolutions submitted by the Board of Directors to the Ordinary Annual General Meeting were published in the French publication for legal announcements (Bulletin des Annonces Légales Obligatoires) on 17 May, 2024 (-officiel.gouv.fr/pages/balo-annonce-unitaire/?q.id=id_annonce:20240517240156460).

The Meeting Notice was published on the June 7, 2024 in the BALO (-officiel.gouv.fr/pages/balo-annonce-unitaire/?q.id=id_annonce:20240607240238969) and in the Official Journal “Les Tablettes Lorraines” () including the procedures for participating and voting and the main methods to exercise shareholders’ rights.

Both of these notices are available on the Company’s website: .

Pursuant to article R. 22-10-23 of the French commercial code, EQUASENS has also made available, since June 5, 2024, all the documents and information prescribed by this article and the voting form on its website - Section Investisseurs, Assemblée Générale tab. The English version of these documents is available on the company's website, by clicking on the EN icon in the Investors section: .

For the purpose of communications between the Company and its shareholders, it is strongly recommended that requests or documents be sent, in priority, by email, to the following address: .

About

With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

  

Listed on Euronext Paris™ - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable

Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)

ISIN: FR 0012882389 – Ticker Code: EQS

Get all the news about the Equasens Group and on

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Frédérique SCHMIDT

Tel. +33 (0)3 83 15 90 67 -

Media Relations:

FIN’EXTENSO - Isabelle APRILE

Tel. +33 (0)6 17 38 61 78 -   

Attachment



EN
10/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

 PRESS RELEASE

EQUASENS ANNONCE SON AGENDA FINANCIER 2026

EQUASENS ANNONCE SON AGENDA FINANCIER 2026 Villers-lès-Nancy, 10 décembre 2026, 18h00 CET – Equasens (isin : FR0012882389 – Mnémo : EQS), leader des solutions numériques pour les professionnels de santé, annonce son agenda financier pour l’exercice 2026. ÉvénementsDatesChiffre d’affaires annuel 20255 février 2026 (après bourse)Résultats annuels 202530 mars 2026 (avant bourse)Chiffre d’affaires du 1er trimestre 202629 avril 2026 (après bourse)Assemblée Générale Annuelle25 juin 2026Chiffre d’affaires du 1er semestre 202630 juillet 2026 (après bourse)Résultats du 1er semestre 202628 septembre ...

 PRESS RELEASE

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year. EventsDates2025 annual revenueFebruary 5, 2026 (after market close)2025 annual resultsMarch 30, 2026 (before market opens)2026 Q1 revenueApril 29, 2026 (after market close)Annual General MeetingJune 25, 20262026 Half-year revenueJuly 30, 2026 (after market close)2026 Half-year resultsSeptember 28, 2026 (before market opens)202...

Aurelien Sivignon
  • Aurelien Sivignon

Equasens : e-health pure player with modest valuation

Equasens provides IT solutions and software for the healthcare industry. Historically positioned in the pharmacy segment (market leader in France, >40% market share), its global expansion (Italy, Germany) and business diversification (nursing homes, hospitals, private practitioners, etc.), should facilitate the return to a dynamic growth trajectory (2025-28 CAGR estimated at +7%) after two challenging years. Given the necessary investments (R&D, salesforce), we believe 2025 will mark a low for m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch